Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RCKT Rocket Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $3.44 +0.8% | $16.00 -2.5% |
| StockIQ Score | 49D+ Moderate Risk: High | 35F Weak Risk: High |
| Technical | 32F | 13F |
| Fundamental | 41D | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Rocket Pharmaceuticals (RCKT) outperforms Ascentage Pharma (AAPG) in nearly every category. RCKT has a stronger investor score (59 vs. 37) and a higher technical score (77 vs. 18), indicating better market performance and trading strength. Its growth score (68 vs. 50) also suggests more promising expansion potential, though both share the same valuation score of 38. AAPG’s weak overall rating contrasts with RCKT’s moderate rating.
